Medicine Description finorate 100mg
Finorate 100mg Capsule is a medication that primarily acts as a lipid-modifying agent. Its active ingredient, fenofibrate, functions by activating peroxisome proliferator-activated receptors (PPARs), particularly PPAR-alpha. This activation leads to enhanced fatty acid oxidation in the liver, decreased triglyceride synthesis, and increased lipoprotein lipase activity. Consequently, this results in the breakdown of triglyceride-rich lipoproteins, thereby lowering triglyceride levels in the bloodstream. Additionally, fenofibrate promotes the production of apolipoproteins A-I and A-II, which are essential components of HDL (high-density lipoprotein) cholesterol, ultimately contributing to the increase of good cholesterol levels within the body. This multifaceted approach helps mitigate the risk of atherosclerosis and related cardiovascular conditions.
Indications and Uses of Finorate 100mg Capsule
- Management of hyperlipidemia, including elevated triglycerides and low-density lipoprotein (LDL) cholesterol levels.
- Assistance in increasing high-density lipoprotein (HDL) cholesterol in patients with low levels.
- Adjunctive treatment in individuals with type 2 diabetes experiencing lipid abnormalities.
- Reduction of cardiovascular disease risk in patients with lipid disorders when lifestyle modifications are insufficient.
Side Effects of Finorate 100mg Capsule
- Abdominal pain
- Nausea
- Headache
- Fatigue
- Muscle pain or weakness
- Skin rash or itching
- Increased liver enzymes
Storage and Handling
Store Finorate 100mg Capsules at room temperature, away from direct light and moisture. Keep out of reach of children and do not use past the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should be advised to adhere to prescribed lifestyle changes, including a heart-healthy diet and regular physical activity, to maximize the benefits of Finorate. Monitoring of liver function tests is recommended during treatment. Inform healthcare providers of any pre-existing conditions or concurrent medications to avoid potential interactions. Regular follow-ups are essential to assess lipid levels and overall treatment efficacy.